Role of Preoperative Hepatobiliary Scintigraphy in Children Requiring Liver Resection

Kailash Chaurasiya1, Elena Kireeva, Mikhail Yadgarov

  • 1From the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.

PubMed

Insights

Assessing future remnant liver function (FRLF) is crucial for preventing posthepatectomy liver failure (PHLF) in children. Hepatobiliary scintigraphy is beneficial for pediatric patients with future remnant liver volume (FRLV) below 25%.

Area of Science:

  • Hepatobiliary scintigraphy
  • Pediatric surgery
  • Liver transplantation

Background:

  • Posthepatectomy liver failure (PHLF) is a significant risk after major liver resection.
  • Future remnant liver function (FRLF) assessment via hepatobiliary scintigraphy is established for adults, but not for pediatric patients.
  • Established adult FRLF threshold is >2.7%/min per m² to prevent PHLF.

Purpose of the Study:

  • To evaluate the utility of FRLF, future remnant liver volume (FRLV), and remnant liver volume to body weight ratio (RLV-BWR) in pediatric patients undergoing liver resection.
  • To determine if existing adult FRLF thresholds are applicable to pediatric populations.
  • To identify optimal parameters for assessing liver function and preventing PHLF in children.

Main Methods:

  • Retrospective analysis of 77 pediatric patients with liver tumors undergoing 1-stage liver resection.
  • Preoperative assessment of FRLF, FRLV, and RLV-BWR.
  • Correlation of these parameters with the occurrence of PHLF.

Main Results:

  • All patients had RLV-BWR >0.5%/kg.
  • FRLV ranged from 19% to 89%, and FRLF ranged from 1.8% to 31.8%/min per m².
  • Two patients developed PHLF (grade A and B); both had FRLV <25% but FRLF >2.7%/min per m².

Conclusions:

  • FRLV and RLV-BWR are useful for preoperative liver assessment in most pediatric cases.
  • FRLF assessment is particularly beneficial for pediatric patients with FRLV <25%.
  • Further prospective studies are needed to establish a definitive FRLV cutoff for pediatric patients.
Abstract